SCHEMBL4072322

SCHEMBL4072322

CC1c2ccccc2-c2c1ccc1ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.42
ALDH1A1 P00352 5/20 0.41
MAPT P10636 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP2A6 P11509 3/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPK1 P28482 2/20 0.39
SLC6A4 P31645 2/20 0.39
LMNA P02545 1/20 0.39
WDR5 P61964 1/20 0.39
TDP2 O95551 1/20 0.38
HPGD P15428 1/20 0.38
ALOX12 P18054 1/20 0.38
CASP3 P42574 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL7937870 0.77 DNMT1 (0.39) DNMT1ALDH1A1MAPTMEN1KMT2A
SCHEMBL18045126 0.77 ALDH1A1 (0.40) DNMT1ALDH1A1MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL8606301 0.76 DNMT1 (0.41) DNMT1ALDH1A1MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL8605086 0.76 DNMT1 (0.41) DNMT1ALDH1A1MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL6558603 0.75 DNMT1 (0.40) DNMT1ALDH1A1MAPTMEN1KMT2A
SCHEMBL29241981 0.74 DNMT1 (0.42) DNMT1ALDH1A1MAPTMEN1KMT2A
SCHEMBL18070183 0.74 DNMT1 (0.36) DNMT1ALDH1A1MAPTMEN1KMT2A
SCHEMBL23443980 0.73 PBRM1 (0.36) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL40599 0.72 GPR3 (0.52) MEN1KMT2ASLC6A4POLBCYP1A2
SCHEMBL29641604 0.72 GPR3 (0.52) MEN1KMT2ASLC6A4POLBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2006278-B2 BENZOFLUORENE COMPOUND AND USE THEREOF TOSOH CORP (JP) 2016-10-12 EP disclosed
US-8993805-B2 Benzofluorene compound and use thereof TOSOH CORPORATION (JP) 2015-03-31 US disclosed
EP-2006278-B1 BENZOFLUORENE COMPOUND AND USE THEREOF TOSOH CORP (JP) 2012-12-26 EP disclosed
EP-2006278-A9 BENZOFLUORENE COMPOUND AND USE THEREOF Tosoh Corporation (JP) 2009-08-05 EP disclosed
US-20090184312-A1 BENZOFLUORENE COMPOUND AND USE THEREOF TOSOH CORPORATION (JP) 2009-07-23 US disclosed
EP-2006278-A2 BENZOFLUORENE COMPOUND AND USE THEREOF Tosoh Corporation (JP) 2008-12-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090184312-A1 BENZOFLUORENE COMPOUND AND USE THEREOF SLC7A1, SLC43A1, SLC7A5 DNMT1 4199/4885ALDH1A1 1932/4885MAPT 1842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.